PacificHealth Laboratories, Inc. (PHLI)
PacificHealth Laboratories, Inc. operates in the Household & Personal Products industry of the Consumer Defensive sector, headquartered in Matawan, NJ, US. The stock last traded at $0.00, up 9900.00% on the session, giving a market capitalisation of $438,307. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -7.0%. Its beta of -329.07 implies it has historically moved less than the broad market.
PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing nutritional products designed to boost overall health and enhance athletic performance for consumers both within the United States and internationally. The company's offerings predominantly target key aspects of athletic performance, such as optimal sports performance, proper hydration, sustained energy (fueling), and efficient muscle recovery. PHLI's product line includes notable items like ENDUROX R4, a drink formulated for muscle recovery; ACCELERADE, a protein-powered sports beverage; energy gels such as ACCEL GEL and 2ND SURGE; the exercise supplement ENDUROX EXCEL; and Body Glove Surge. Additionally, they provide ACCELERADE HYDRO, a specific formulation for less intense workouts, which supports hydration, energy, and recovery before, during, and after physical activity. Reaching consumers through diverse distribution channels, PHLI's products are available in sports specialty and natural product retailers and chains, as well as directly through their official website. PacificHealth Laboratories, Inc. was founded in 1995 and is headquartered in Matawan, New Jersey.
PacificHealth Laboratories, Inc. is most often compared with the following Consumer Defensive names: